I. Pete

发表

MEK 1 is associated with carboplatin resistance and is a prognostic biomarker in epithelial ovarian cancer

C. Denkert, A. Lánczky, Zsófia Pénzváltó, 2014 .

MEK1 is associated with carboplatin resistance and is a prognostic biomarker in epithelial ovarian cancer

C. Denkert, A. Lánczky, B. Győrffy, 2014, BMC Cancer.

Predictive biomarkers of platinum and taxane resistance using the transcriptomic data of 1816 ovarian cancer patients.

B. Győrffy, Á. Osz, J. Fekete, 2020, Gynecologic oncology.

Prediction of cervical infiltration in Stage II endometrial cancer by different preoperative evaluation techniques (D&C, US, CT, MRI).

T. Pulay, I. Pete, B. Pete, 2003, European journal of gynaecological oncology.

SUCCOR Risk: Design and Validation of a Recurrence Prediction Index for Early-Stage Cervical Cancer

P. Rolland, F. Guyon, B. Chiofalo, 2022, Annals of Surgical Oncology.

Investigation of serum sex hormone levels in postmenopausal patients with multiple benign breast lesions detected by mammography

N. Udvarhelyi, B. Budai, I. Pete, 1998 .

The value of colposcopy in screening cervical carcinoma.

V. Tóth, I. Pete, P. Bösze, 1998, European journal of gynaecological oncology.

Currently favored sampling practices for tumor sequencing can produce optimal results in the clinical setting

B. Győrffy, G. Munkácsy, L. Pongor, 2020, Scientific Reports.

Meta‐analysis of gene expression profiles associated with histological classification and survival in 829 ovarian cancer samples

B. Györffy, E. Raso, G. Munkácsy, 2012, International journal of cancer.

Evaluation of the Accuracy of Preoperative MRI in Measuring Myometrial Infiltration in Endometrial Carcinoma

I. Pete, M. Gődény, K. Horváth, 2014, Pathology & Oncology Research.

High-Throughput Sequencing-Based Investigation of Viruses in Human Cancers by Multienrichment Approach

O. Lund, T. Sicheritz-Pontén, S. Brunak, 2019, The Journal of infectious diseases.

Mixed Ovarian Tumor Composed of Brenner Tumor and Adult-Type Granulosa Cell Tumor: A Case Report of a Very Rare Mixed Ovarian Tumor and a Review of the Literature

I. Pete, J. Tamás, E. Toth, 2018, International journal of surgical pathology.

Maintenance olaparib in patients (pts) with platinum-sensitive relapsed ovarian cancer (PSROC) by somatic (s) or germline (g) BRCA and other homologous recombination repair (HRR) gene mutation status: Overall survival (OS) results from the ORZORA study.

A. Oza, R. Glasspool, S. Pignata, 2022, Journal of Clinical Oncology.

ORZORA: Maintenance olaparib in patients with platinum-sensitive relapsed ovarian cancer: outcomes by somatic and germline BRCA and other homologous recombination repair gene mutation status

A. Oza, R. Glasspool, S. Pignata, 2021, Gynecologic Oncology.

MEK1 is associated with carboplatin resistance and is a prognostic biomarker in epithelial ovarian cancer

C. Denkert, A. Lánczky, Zsófia Pénzváltó, 2014, BMC Cancer.

Treatment Patterns, Health Care Utilization, and Costs of Ovarian Cancer in Central and Eastern Europe Using a Delphi Panel Based on a Retrospective Chart Review

T. Bozanovic, L. Bodnar, V. Pažin, 2013, International Journal of Gynecologic Cancer.

[Synchronous tumors of the female genital tract: triple malignant and one benign tumor].

I. Pete, I. Vereczkey, A. Dudnyikova, 2012, Magyar onkologia.

Maintenance olaparib in patients with platinum-sensitive relapsed ovarian cancer: Outcomes by somatic and germline BRCA and other homologous recombination repair gene mutation status in the ORZORA trial.

A. Oza, R. Glasspool, S. Pignata, 2023, Gynecologic oncology.

SUCCOR Nodes: May Sentinel Node Biopsy Determine the Need for Adjuvant Treatment?

P. Rolland, F. Guyon, B. Chiofalo, 2023, Annals of Surgical Oncology.

The fate of the retained ovaries following radical hysterectomy.

I. Pete, P. Bősze, 1998, European journal of gynaecological oncology.